Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine

Cardiovascular and metabolic disease (CVMD) is becoming increasingly prevalent in developed and developing countries with high morbidity and mortality. In recent years, fibroblast growth factor 21 (FGF21) has attracted intensive research interest due to its purported role as a potential biomarker an...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Huiling, Yue, Tong, Chen, Zhengfang, Wu, Weiming, Xu, Suowen, Weng, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760446/
https://www.ncbi.nlm.nih.gov/pubmed/36594101
http://dx.doi.org/10.7150/ijbs.73936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760446/
https://www.ncbi.nlm.nih.gov/pubmed/36594101
http://dx.doi.org/10.7150/ijbs.73936

Ejemplares similares